JAMES LEE to Pharmacogenetics
This is a "connection" page, showing publications JAMES LEE has written about Pharmacogenetics.
Connection Strength
0.976
-
Results of the ACCOuNT Trial: A Multi-Institutional Prospective Pharmacogenomics Implementation Trial for African American Inpatients. Clin Pharmacol Ther. 2026 Jan; 119(1):109-119.
Score: 0.215
-
The Pharmacogenomics Global Research Network Implementation Working Group: global collaboration to advance pharmacogenetic implementation. Pharmacogenet Genomics. 2025 Jan 01; 35(1):1-11.
Score: 0.202
-
Pharmacogenomics of medications given via nonconventional administration routes: a scoping review. Pharmacogenomics. 2022 11; 23(17):933-948.
Score: 0.177
-
Multisite investigation of strategies for the clinical implementation of pre-emptive pharmacogenetic testing. Genet Med. 2021 12; 23(12):2335-2341.
Score: 0.162
-
Multi-site investigation of strategies for the clinical implementation of CYP2D6 genotyping to guide drug prescribing. Genet Med. 2019 10; 21(10):2255-2263.
Score: 0.137
-
Pharmacist-guided pharmacogenetic service lowered warfarin-related hospitalizations. Pharmacogenomics. 2023 04; 24(6):303-314.
Score: 0.046
-
Impact of the CYP2C19*17 Allele on Outcomes in Patients Receiving Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention. Clin Pharmacol Ther. 2021 03; 109(3):705-715.
Score: 0.038